Literature DB >> 8524414

Identification of the breast cancer susceptibility gene BRCA2.

R Wooster1, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem.   

Abstract

In Western Europe and the United States approximately 1 in 12 women develop breast cancer. A small proportion of breast cancer cases, in particular those arising at a young age, are attributable to a highly penetrant, autosomal dominant predisposition to the disease. The breast cancer susceptibility gene, BRCA2, was recently localized to chromosome 13q12-q13. Here we report the identification of a gene in which we have detected six different germline mutations in breast cancer families that are likely to be due to BRCA2. Each mutation causes serious disruption to the open reading frame of the transcriptional unit. The results indicate that this is the BRCA2 gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524414     DOI: 10.1038/378789a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  852 in total

1.  A highly accurate, low cost test for BRCA1 mutations.

Authors:  N J van Orsouw; R K Dhanda; Y Elhaji; S A Narod; F P Li; C Eng; J Vijg
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

2.  Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.

Authors:  L N Lodder; P G Frets; R W Trijsburg; E J Meijers-Heijboer; J G Klijn; H J Duivenvoorden; A Tibben; A Wagner; C A van der Meer; P Devilee; C J Cornelisse; M F Niermeijer
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

3.  Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.

Authors:  B H Spain; C J Larson; L S Shihabuddin; F H Gage; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Founder BRCA1/2 mutations among male patients with breast cancer in Israel.

Authors:  J P Struewing; Z M Coriaty; E Ron; A Livoff; M Konichezky; P Cohen; M B Resnick; B Lifzchiz-Mercerl; S Lew; J Iscovich
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

5.  A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines.

Authors:  T Chen; F M Boisvert; D P Bazett-Jones; S Richard
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

Review 6.  Expression of BRCA1 and BRCA2 in normal and neoplastic cells.

Authors:  L A Chodosh
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

Review 7.  Genes and generalists: why we need professionals with added competencies.

Authors:  P P Reynolds; J L Benkendorf
Journal:  West J Med       Date:  1999 Nov-Dec

8.  Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.

Authors:  K Aktan-Collan; J P Mecklin; A de la Chapelle; P Peltomäki; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  2000-02       Impact factor: 6.318

Review 9.  Molecular genetics of ovarian cancer.

Authors:  A N Shelling; W Foulkes
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

10.  Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women's attitudes.

Authors:  Barbara A Bernhardt; Gail Geller; Misha Strauss; Kathy J Helzlsouer; Michael Stefanek; Patti M Wilcox; Neil A Holtzman
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.